Track Your CD4 Count and Viral Load! Use TheBody.com's New Health Tracker!

HIV/AIDS Basics & Prevention

Just Diagnosed

HIV Treatment

Living With HIV

AIDS Policy & Activism

HIV Around the World

Conference Coverage

Retrovir (Zidovudine, AZT)

The Basics | News | Research

See also: Drug Interactions | Medication Side Effects

Show Archived (Historical) Articles

Brand Name:	Retrovir
Generic Name:	Zidovudine, AZT
Adult Single Dose:	One 300-mg tablet (twice a day)
Food & Liquid Restrictions:	None
Drug Class:	NRTI

The Basics

An Overview of Retrovir (Zidovudine, AZT) (Regularly Updated)
To read PDF, click here
From U.S. National Institutes of Health
Retrovir (March/April 2009)
To read PDF, click here
In Positively Aware, from Test Positive Aware Network
Zidovudine (Retrovir, AZT) (March 15, 2009)
To read PDF, click here
From AIDS InfoNet
AZT (Retrovir, Zidovudine, ZDV) (September 28, 2008)
Basic information on dosing schedules and side effects.
From U.S. Department of Veterans Affairs
Patient Information About Retrovir (Zidovudine, AZT) Oral Solution (PDF) (September 2008)
From GlaxoSmithKline
AZT (zidovudine, Retrovir) (October 19, 2006)
From AIDS Treatment Data Network
Patient Information About Retrovir (Zidovudine, AZT) IV Infusion (PDF) (October 2006)
From GlaxoSmithKline
Retrovir (Zidovudine) (November 2005)
To read PDF, click here
From The Center for AIDS

News

GlaxoSmithKline Announces New Program to Provide Financial Assistance for Eligible HIV Patients in the U.S. (November 11, 2008)
If you live in the United States, use private health insurance and take Combivir (AZT/3TC), Epzicom (abacavir/3TC, Kivexa), Lexiva (fosamprenavir, Telzir) or another HIV drug made by GlaxoSmithKline, you may have a chance to save a nice chunk of change.
From GlaxoSmithKline
FDA Approves First Generic HIV/AIDS Drug in Capsule Form for United States Market (March 31, 2006)
From U.S. Food and Drug Administration
A Bitter-Sweet Pill (March 2006)
The first ever HIV drug, AZT, has a checkered history. What's next for the drug as it comes off patent in the UK?.
From Positive Nation
WHO Removes Cipla's Lamivudine, Zidovudine Generics From Approved Drug List (June 16, 2004)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation

Research

Studies Raise Possible Long-Term Concern for Infants Exposed to Retrovir in Womb (April 16, 2007)
From aidsmap.com
HIV JournalView: Study Ties Insulin Resistance to NRTIs, Not PIs (September 2005)
d4T and 3TC are associated with insulin resistance and high insulin levels; indinavir is associated only with elevated insulin levels; and no link to insulin abnormalities is found for AZT or ddI.
From The Body PRO
Incidence of Zidovudine-Associated Anemia May Be Lower Than Initially Thought -- Particularly With Fixed-Dose Combinations (July 26, 2005)
In The 3rd International AIDS Society Conference on HIV Pathogenesis and Treatment

The Body is a service of Body Health Resources Corporation, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Body Health Resources Corporation, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.